VAERS 2557562
SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ918AB
- Staat
- NH
- Alter
- 91,0
- Geschlecht
- F
- Eingang
- 11.01.2023
- Impfdatum
- 10.10.2022
- Beginn
- 07.01.2023
- Tage bis Beginn
- 89,0
- Dosis
- 1
- Route/Site
- - / -
Symptomtext
Discharge Provider: MD Primary Care Provider: DO Admission Date: 1/7/2023 Discharge Date: Jan 10, 2023 COVID positive date: 01/07/2023 PRESENTING PROBLEM: Acute on chronic diastolic congestive heart failure (HCC) [I50.33] Acute cystitis without hematuria [N30.00] Acute respiratory failure with hypoxia (HCC) [J96.01] Acute on chronic respiratory failure (HCC) [J96.20] Community acquired pneumonia, unspecified laterality [J18.9] Sepsis with acute hypoxic respiratory failure without septic shock, due to unspecified organism (HCC) [A41.9, R65.20, J96.01] Pneumonia due to COVID-19 virus [U07.1, J12.82] HOSPITAL COURSE: 91yo female w/ h/o aortic stenosis and A-fib who presents from skilled nursing facility for shortness of breath. Of note, she had recently tested positive for COVID-19 on 1/6. The patient wears O2 at night. In the ED, initial labs were remarkable for BNP of 1930, WBC of 13.9, and procal of 0.27. CXR showed some cardiomegaly with pulmonary vascular congestion. High sensitivity troponin was elevated but flat and there were no EKG changes; troponin was discussed with cardiology and it was thought to be related to demand ischemia and not ACS. Patient was started on ceftriaxone and azithromycin, remdesivir, as well as steroids and lasix and admitted to the hospital. Patient was quickly able to go down to room air during the day. No bacterial pathogen was isolated and it was thought to be less likely that she was suffering from a secondary bacterial illness. She had a urine culture that had come back positive for klebsiella pneumonia and ABX were continued in the form of ceftriaxone. Patient had a good diuretic response to lasix but with her history of AS and avanced age, decision was made to to keep her on diuretics indefinitely as she appeared overall euvolemic. As the patient clinically improved, decision was made to transition her back to her skilled nursing facility. As she was on room air during the day, she was not continued on steroids. As she had completed 4 days of ABX for a UTI and there was less suspicion for a bacterial pneumonia, ABX were not continued. Lasix was continued for 3 more days. Patient was discharged in stable condition.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Acute on chronic respiratory failure with hypoxia (HCC) Pneumonia due to COVID-19 virus Acute on chronic respiratory failure (HCC) Nonrheumatic aortic valve stenosis Essential (primary) hypertension Chronic heart failure with preserved ejection fraction (HCC) Paroxysmal A-fib (HCC) Dysphagia Protein-calorie malnutrition, unspecified severity (HCC) Acute cystitis without hematuria Urine retention Dehydration Hypoxemia Closed left hip fracture, sequela Pressure injury of coccygeal region, stage 4 (HCC)
- Andere Medikamente
- acetaminophen (TYLENOL) 500 MG tablet aluminum, magnesium & simethicone (MYLANTA) 200-200-20 MG/5ML SUSP suspension amiodarone (PACERONE) 200 MG tablet amLODIPine (NORVASC) 5 MG tablet aspirin 81 MG enteric coated tablet furosemide (LASIX)
- Allergien
- NKA
- Vorherige Impfungen
- -